Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 39.47M P/E - EPS this Y 88.50% Ern Qtrly Grth -
Income -4.2M Forward P/E -14.88 EPS next Y 233.30% 50D Avg Chg 9.00%
Sales 31.79M PEG - EPS past 5Y - 200D Avg Chg 11.00%
Dividend N/A Price/Book 0.96 EPS next 5Y - 52W High Chg -66.00%
Recommedations 1.50 Quick Ratio 5.14 Shares Outstanding 16.64M 52W Low Chg 72.00%
Insider Own 5.01% ROA -4.86% Shares Float 24.69M Beta 0.34
Inst Own 24.26% ROE -9.65% Shares Shorted/Prior 79.76K/111.60K Price 2.38
Gross Margin 73.86% Profit Margin -13.20% Avg. Volume 52,890 Target Price 10.85
Oper. Margin 2.04% Earnings Date - Volume 3,252 Change 1.71%
About Brainsway Ltd.

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

Brainsway Ltd. News
04/24/24 BrainsWay to Report First Quarter 2024 Financial Results on May 8, 2024
04/17/24 BrainsWay Expands Deep TMS™ Access in Israel Following Significant Increase in Reimbursement Rates
04/04/24 BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS™ to Treat Parkinson's Disease
07:00 AM BrainsWay Announces Positive Results in Late-Life Depression Post-Marketing Analysis
03/27/24 After Plunging -13.63% in 4 Weeks, Here's Why the Trend Might Reverse for Brainsway (BWAY)
03/18/24 All You Need to Know About Brainsway Ltd. Sponsored ADR (BWAY) Rating Upgrade to Buy
03/18/24 BrainsWay Broadens Partnership with Katie’s Way Plus Through Order of an Additional 18 Deep TMS™ Systems
03/06/24 BrainsWay Reports Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights
03/05/24 What's in the Offing for Brainsway (BWAY) in Q4 Earnings?
02/21/24 BrainsWay to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024
02/06/24 7 High-Growth Stocks to Snag for Spectacular Returns in 2024
01/25/24 Biotech Stocks Are on Fire: Here Are the Top 3 Picks for January
01/10/24 BrainsWay Initiates Clinical Evaluation of Rotational Field “Deep TMS 360°™” Technology
01/03/24 Recent Price Trend in Brainsway Ltd. Sponsored ADR (BWAY) is Your Friend, Here's Why
12/27/23 Does Brainsway Ltd. Sponsored ADR (BWAY) Have the Potential to Rally 48.15% as Wall Street Analysts Expect?
12/22/23 Are Medical Stocks Lagging Brainsway (BWAY) This Year?
12/22/23 7 Under-the-Radar Stocks Gearing Up for a 2025 Breakthrough
12/19/23 BrainsWay Highlights Expanded Deep TMS™ Access with Growing Western U.S. Network
12/14/23 Brainsway Ltd. Sponsored ADR (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why
12/11/23 Wall Street Analysts Predict a 68.72% Upside in Brainsway Ltd. Sponsored ADR (BWAY): Here's What You Should Know
BWAY Chatroom

User Image Stock_Titan Posted - 3 days ago

$BWAY BrainsWay to Report First Quarter 2024 Financial Results on May 8, 2024 https://www.stocktitan.net/news/BWAY/brains-way-to-report-first-quarter-2024-financial-results-on-may-8-c68y5qbpi7ry.html

User Image DonCorleone77 Posted - 1 week ago

$BWAY Brainsway expands Deep TMS access in Israel BrainsWay announced the further expansion of access to its Deep TMS treatment in Israel. BrainsWay has steadily increased its presence in the country with 11 recent system installations, and this momentum has been driven in part by a 45% increase in reimbursement rates. The Company expects to have additional Deep TMS systems installed in Israel by the end of 2024. "BrainsWay continues to make significant strides in expanding its international footprint, and it is extremely meaningful for us to be able to offer our life altering Deep TMS therapy to mental health patients across Israel," said Hadar Levy, Chief Executive Officer of BrainsWay. "Following recent events in the country, serious mental health conditions are on the rise, and it is profoundly important to us that Deep TMS be made available to as many patients as possible," concluded Levy.

User Image Stock_Titan Posted - 1 week ago

$BWAY BrainsWay Expands Deep TMS™ Access in Israel Following Significant Increase in Reimbursement Rates https://www.stocktitan.net/news/BWAY/brains-way-expands-deep-tms-access-in-israel-following-significant-yeb6kzz05jxm.html

User Image Stocks4thought Posted - 2 weeks ago

$BWAY Back to the bricks$ MR Floyd.

User Image SuperBusa Posted - 2 weeks ago

$RVSN $ALAR $BWAY $FRSX $INCR

User Image Stock_Titan Posted - 3 weeks ago

$BWAY BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS™ to Treat Parkinson's Disease https://www.stocktitan.net/news/BWAY/brains-way-announces-published-review-results-highlighting-potential-h4rydumm7rf7.html

User Image stockregion Posted - 4 weeks ago

A Glimmer of Hope: Revolutionizing Late-Life Depression Treatment with Deep TMS Technology. Depression is a formidable adversary at any age, but it poses unique challenges for the elderly. Traditional treatments often fall short, leaving a gap that demands innovative solutions. Enter Deep Transcranial Magnetic Stimulation (Deep TMS) technology, a beacon of hope for those battling late-life depression. Recent findings from BrainsWay have cast a spotlight on this groundbreaking approach, underscoring its potential to transform lives. $BWAY https://stockregion.app/p/medical-technology-company-reveals

User Image DonCorleone77 Posted - 4 weeks ago

$BWAY Brainsway announces results in late-life depression post-marketing analysis BrainsWay announced positive results in a recently published post-marketing study of its Deep Transcranial Magnetic Stimulation for the treatment of late-life depression. The data were highlighted in an article entitled, "Never Too Late: Safety and Efficacy of Deep TMS for Late-Life Depression," that was published in the Journal of Clinical Medicine, an international, peer-reviewed, open access journal. The post-marketing study demonstrated real-world outcomes for older adults suffering from major depressive disorder. In the study, data was analyzed from 247 depression patients at 16 clinical sites in this age group who had been treated with BrainsWay's proprietary H1 Coil. The results showed a 79.4% response rate and a 60.3% remission rate for those patients who had received at least 30 treatment sessions, and were based on the rating scale that was most utilized for each individual patient....

User Image TheTradeXchange Posted - 4 weeks ago

$BWAY - BrainsWay Announces Positive Results in Late-Life Depression Post-Marketing AnalysisData Published in Leading Peer-Reviewed Publication, Journal of Clinical Medicine

User Image Stock_Titan Posted - 4 weeks ago

$BWAY BrainsWay Announces Positive Results in Late-Life Depression Post-Marketing Analysis https://www.stocktitan.net/news/BWAY/brains-way-announces-positive-results-in-late-life-depression-post-tlqb7zgkaril.html

User Image Stocks4thought Posted - 1 month ago

$STIM This changes the customer base tremendously- how quick an uptake and revenue translation. Honestly, missed the early gains in stock- was watching $BWAY any help?

User Image Stock_Titan Posted - 1 month ago

$BWAY BrainsWay Broadens Partnership with Katie’s Way Plus Through Order of an Additional 18 Deep TMS™ Systems https://www.stocktitan.net/news/BWAY/brains-way-broadens-partnership-with-katie-s-way-plus-through-order-m21ujah3w1g4.html

User Image Stocks4thought Posted - 1 month ago

$BWAY New high comning

User Image itisgame Posted - 1 month ago

$BWAY /OPRA/ https://investor.opera.com/news-releases/news-release-details/opera-welcomes-opening-ios-other-browser-engines-announces-its

User Image Imran26 Posted - 1 month ago

$SRTS a friend saw them on the American academy of Derm show. The booth was impressive, expansive and empty. SkinCure had a very active booth. There’s a third entrant to the competition, a company called XSTRAHL. There’s going to be an all out war Three companies have the technology, each claims the other is crap. Only one (SkinCure) has the market access. I wonder how fast can the other two latch on an existing distribution channel. If it happens fast the reward is huge because SkinCure will have to worj through 350 older devices, while sensus will build the services (hopefully with some existing presence in clinics) Look at $BWAY how it tripled when they went from selling hardware to selling full solution. Short term $SRTS will see lows, that’s an opportunity

User Image Stocks4thought Posted - 1 month ago

$BWAY Stocks4thought Mar 06, 2024 7:14 AM $CRDF Page 4/5 slide - Just beginning- the dream ot $MAIA $INDP $BWAY - investors.cardiffoncology.c... MY Cousin VINNY now showing at drive ins across America $VINC

User Image Stocks4thought Posted - 1 month ago

$BWAY HOE DO$

User Image Persent12 Posted - 1 month ago

$BWAY Zack's upgrades to #1 over the weekend. Same with $LFWD . Bought both this morning. Only a few hundred shares so far. Let's see the morning market action. $BWAY price target upped a dollar by Wainwright this morning....

User Image Spaggett Posted - 1 month ago

$BWAY scooped 1000 on friday 🍨

User Image Stocks4thought Posted - 1 month ago

$CRDF Page 4/5 slide - Just beginning- the dream ot $MAIA $INDP $BWAY - https://investors.cardiffoncology.com/static-files/837a64fe-a778-4209-9239-313d77a3aa0f MY Cousin VINNY now showing at drive ins across America $VINC

User Image epsguid Posted - 1 month ago

$BWAY reported $0.00, consensus was ($0.03) via @eWhispers #epsbeat http://eps.sh/d/bway

User Image DonCorleone77 Posted - 1 month ago

$BWAY Brainsway reports Q4 EPS 0c vs 12c last year Reports Q4 revenue $9.029M vs $6.033M last year. "Our annual 2023 revenues of $31.8 million represented an increase of 17% over full-year 2022, reflecting the strong and growing demand for our innovative Deep TMS technology," said Hadar Levy, BrainsWay's Chief Executive Officer. "In the fourth quarter we generated positive net income, and for the second consecutive quarter, recorded positive Adjusted EBITDA1 and positive cash flow from operations."

User Image Stock_Titan Posted - 1 month ago

$BWAY BrainsWay Reports Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights https://www.stocktitan.net/news/BWAY/brains-way-reports-fourth-quarter-and-full-year-2023-financial-mea3cc1hh7sh.html

User Image Stocks4thought Posted - 1 month ago

$STOK ot MAJOR $bway https://www.foxnews.com/health/researchers-sources-four-brain-disorders-new-treatments OT $slno $vktx $alt

User Image swingingtech Posted - 1 month ago

$BWAY https://wallstreetwaves.com/whats-in-the-offing-for-brainsway-bway-in-q4-earnings/

User Image Stocks4thought Posted - 1 month ago

$VINC Other girls $BWAY https://www.foxnews.com/health/researchers-sources-four-brain-disorders-new-treatments $SLNO $VYGR

User Image Stocks4thought Posted - 1 month ago

$BWAY https://www.foxnews.com/health/researchers-sources-four-brain-disorders-new-treatments

User Image Stocks4thought Posted - 02/29/24

$BWAY Coming into town with earnings. Sector sexy.

User Image NJgolfer Posted - 2 months ago

$bway huge cwh pattern going back to April 22, so 2 years long. Hold above $5.45. On watch for next two weeks

User Image maixem Posted - 2 months ago

$BWAY

Analyst Ratings
HC Wainwright & Co. Buy Mar 11, 24
Oppenheimer Outperform Nov 16, 23
Raymond James Market Perform Nov 16, 23
HC Wainwright & Co. Buy Sep 22, 23
HC Wainwright & Co. Buy Sep 6, 23
HC Wainwright & Co. Buy Aug 24, 23
HC Wainwright & Co. Buy Aug 21, 23
HC Wainwright & Co. Buy Jun 5, 23
Oppenheimer Outperform May 18, 23